Compare Charles Schwab Corporation Common Stock (SCHW) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles Schwab Corporation Common Stock vs DENTSPLY SIRONA Inc — how do they compare? Charles Schwab Corporation Common Stock trades at $96.64 (market cap $167.52B), while DENTSPLY SIRONA Inc trades at $8.79 (market cap $1.73B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 96.8× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals — on Pluang, investors hold Charles Schwab Corporation Common Stock for 85 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| SCHW | XRAY | |
|---|---|---|
Market Cap | $167.52B | $1.73B |
Volume | 6,554,126 | 6,198,582 |
Sector | Financials | Health |
52-Week High | $113.65 | $14.68 |
52-Week Low | $85.35 | $8.52 |
Typical Hold Time | 85 Days | 72 Days |
Enterprise Value | $153.97B | $3.80B |
Dividend Yield | 1.32% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles Schwab (SCHW) trades at $95.58, down 1.26% today, amid bearish technical signals despite strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $1.62 exceeding expectations of $1.56, while revenue grew to $23.92B in 2025. Analyst consensus remains bullish with a $119.92 price target, though technical indicators show selling pressure with RSI at oversold levels and bearish moving average alignment.
SCHW presents a compelling value opportunity with attractive valuation metrics (P/E 17.64) and robust profitability (ROE 22.45%), but faces near-term technical headwinds and market volatility risks. The company's expansion into AI integration and Texas Stock Exchange listing provides growth catalysts, though investors should monitor interest rate sensitivity and competitive pressures in the brokerage sector.
DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.
The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
